{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Dare Bioscience, Inc."},"Symbol":{"label":"Symbol","value":"DARE"},"Address":{"label":"Address","value":"3655 NOBEL DRIVE,SUITE 260, SAN DIEGO, California, 92122, United States"},"Phone":{"label":"Phone","value":"+1 858 926-7655"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream."},"CompanyUrl":{"label":"Company Url","value":"https://www.darebioscience.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Annie Thurman","title":"Medical Director"},{"name":"Christine Mauck","title":"Medical Director"},{"name":"David Friend","title":"Chief Scientific Officer"},{"name":"Jessica Hatheway","title":"Vice President-Clinical Operations"},{"name":"Mark Walters","title":"Vice President-Operations"},{"name":"Sabrina Martucci Johnson","title":"President, CEO, Secretary & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}